This study also highlights that serum ITGB2 expression was discriminately expressed in RA and OA patients and showed sufficient diagnostic accuracy, delineating it as a surrogate circulating biomarker of RA and OA. This evidence concerns the gene ITGB2 and rheumatoid arthritis.